Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Investigating the role of the complement system in sickle cell disease
EF 2021-22
Résumé
Sickle cell disease (SCD) is a life-threatening red blood cell (RBC) disorder that impacts millions of people across the globe and is caused by an inherited change in the protein in RBCs that carries oxygen throughout the body. This results in sickled RBCs that are stiff and prone to getting stuck in small blood vessels, thereby impeding the flow of oxygen to organs and causing extremely painful episodes in patients. This poses an increased risk for serious organ damage, lower quality of life, and premature death. With very few treatment options available, gaining a more comprehensive understanding of the disease is necessary to develop more effective treatments. Recent research points to the complement system having a role in SCD pathogenesis. Sickled RBCs ; especially when ruptured ; can over-activate complement proteins, which are deposited on the surface of blood vessels, causing injury and increasing the risk for clot formation. Complement can also activate immune cells known as neutrophils, causing the formation of sticky net-like traps that increase inflammation, and contribute to clotting. I aim to use a large cohort of pediatric SCD patient samples (collected during crisis episodes and after recovery) to confirm complement over-activation in patients. Then, I will examine the functional consequences of this over-activation on endothelial cells and neutrophils (e.g., increased clot formation, changes in cell activation) in a 2D in vitro model of the vascular environment. Hopefully, my results will point towards new treatment targets and thus help to improve SCD patient outcomes. Importantly, our study is especially relevant to patients of African descent, an often understudied and underserved group in medical research, who are most impacted by SCD.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
466825
Name
Diatlov Daniel
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating the role of the complement system in sickle cell disease
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Complement; Endothelial Cells; Neutrophils; Sickle Cell Disease; Vascular Biology
Abstract
Sickle cell disease (SCD) is a life-threatening red blood cell (RBC) disorder that impacts millions of people across the globe and is caused by an inherited change in the protein in RBCs that carries oxygen throughout the body. This results in sickled RBCs that are stiff and prone to getting stuck in small blood vessels, thereby impeding the flow of oxygen to organs and causing extremely painful episodes in patients. This poses an increased risk for serious organ damage, lower quality of life, and premature death. With very few treatment options available, gaining a more comprehensive understanding of the disease is necessary to develop more effective treatments. Recent research points to the complement system having a role in SCD pathogenesis. Sickled RBCs ; especially when ruptured ; can over-activate complement proteins, which are deposited on the surface of blood vessels, causing injury and increasing the risk for clot formation. Complement can also activate immune cells known as neutrophils, causing the formation of sticky net-like traps that increase inflammation, and contribute to clotting. I aim to use a large cohort of pediatric SCD patient samples (collected during crisis episodes and after recovery) to confirm complement over-activation in patients. Then, I will examine the functional consequences of this over-activation on endothelial cells and neutrophils (e.g., increased clot formation, changes in cell activation) in a 2D in vitro model of the vascular environment. Hopefully, my results will point towards new treatment targets and thus help to improve SCD patient outcomes. Importantly, our study is especially relevant to patients of African descent, an often understudied and underserved group in medical research, who are most impacted by SCD.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Diatlov, Daniel
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~